Physician profile
Sanjeev K Gulati
NPI 1578574638
$406,003.73
in general payments reported to CMS, 2019-2025
14 companies · $154K in 2025
The $154K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93K · 2020: $17K · 2021: $27K · 2022: $33K · 2023: $18K · 2024: $64K · 2025: $154K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $138K · Consulting Fee: $71K · Travel and Lodging: $18K · Food and Beverage: $9,924.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $137,825.00 |
| Consulting Fee | $70,860.50 |
| Travel and Lodging | $17,700.56 |
| Food and Beverage | $9,923.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $119,010.03 | 2021-2025 | Cobalt Dr Mri Surescan, Cardioinsight, Mycarelink |
| Abbott Laboratories | $87,598.80 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, 2nd Gen Centrimag Primary Console |
| Boston Scientific Corporation | $72,425.19 | 2019-2025 | General - Therapies, Resonate El Icd Vr, Emblem Mri S-Icd |
| Medtronic Vascular, INC. | $49,045.68 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $36,442.31 | 2019 | |
| Procyrion, INC. | $16,505.77 | 2021-2025 | Aortix System |
| Biotronik INC. | $10,122.47 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $10,089.23 | 2020-2023 | Optimizer |
| Bayer Healthcare Pharmaceuticals INC. | $3,840.00 | 2021 | |
| Cvrx, INC. | $305.83 | 2022-2024 | Barostim Neo System |
| Abiomed | $252.97 | 2025 | |
| Siemens Medical Solutions USA, INC. | $170.24 | 2025 | Acuson Origin Diagnostic Ultrasound System |
| Janssen Scientific Affairs, LLC | $161.46 | 2023 | Xarelto |
| Janssen Pharmaceuticals, INC | $33.75 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjeev Gulati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.